Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Palisade Bio (PALI) Revenue (2016 - 2025)

Historic Revenue for Palisade Bio (PALI) over the last 14 years, with Q3 2025 value amounting to -$5000.0.

  • Palisade Bio's Revenue changed N/A to -$5000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$8000.0, marking a year-over-year change of. This contributed to the annual value of $250000.0 for FY2023, which is N/A changed from last year.
  • As of Q3 2025, Palisade Bio's Revenue stood at -$5000.0.
  • In the past 5 years, Palisade Bio's Revenue ranged from a high of $250000.0 in Q1 2023 and a low of -$1.7 million during Q1 2021
  • Moreover, its 3-year median value for Revenue was -$5000.0 (2025), whereas its average is -$307142.9.
  • The largest annual percentage gain for Palisade Bio's Revenue in the last 5 years was 114000.0% (2021), contrasted with its biggest fall of 2852192.69% (2021).
  • Over the past 3 years, Palisade Bio's Revenue (Quarter) stood at -$26000.0 in 2021, then skyrocketed by 1061.54% to $250000.0 in 2023, then plummeted by 102.0% to -$5000.0 in 2025.
  • Its Revenue was -$5000.0 in Q3 2025, compared to -$2000.0 in Q2 2025 and -$1000.0 in Q1 2025.